Cardivas IN 6.25/5 Tablet Benefits & Uses

Cardivas IN 6.25/5 Tablet is used to treat the following -

Main Benefits

High BP (Read More - Home Remedies for High Blood Pressure)

Other Benefits

Cardivas IN 6.25/5 Tablet Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group

Dosage

Cardivas IN 6.25/5 Tablet Side Effects

Based on research, the following side effects have been observed when Cardivas IN 6.25/5 Tablet is used -

Severe

Dizziness (Read More - Home Remedies for Dizziness: Quick Tips for Instant Relief)
Bradycardia
Difficulty breathing

Moderate

Blurred vision
Wheezing
Hypertension

Mild

Nausea or vomiting
Headache
Fatigue
पेट दर्द
Diarrhoea

Common

Irregular heartbeat
Chest Pain
Shortness of Breath (Read More - How to Treat Shortness of Breath at Home: Natural Solutions)
Fainting

Cardivas IN 6.25/5 Tablet Related Warnings

Is the use of Cardivas IN 6.25/5 Tablet safe for pregnant women?

Pregnant women may get severe side effects after taking Cardivas IN. If you are pregnant, do not take Cardivas IN without a doctor's advice.
Is the use of Cardivas IN 6.25/5 Tablet safe during breastfeeding?

In the absence of any scientific study about the side effects of Cardivas IN in breastfeeding women, information on safety of Cardivas IN is unavailable.
What is the effect of Cardivas IN 6.25/5 Tablet on the Kidneys?

Cardivas IN rarely affects the kidneys.
What is the effect of Cardivas IN 6.25/5 Tablet on the Liver?

Cardivas IN has very mild side effects on the liver.
What is the effect of Cardivas IN 6.25/5 Tablet on the Heart?

Cardivas IN may have mild side effects on the heart. Most people will never see any effect on the heart.

Severe Interaction of Cardivas IN 6.25/5 Tablet with Other Drugs

Cardivas IN 6.25/5 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Amiodarone

Clonidine

Verapamil

Formoterol

Salmeterol

Amiodarone

Azithromycin

Amoxicillin,Omeprazole,Clarithromycin

Ciprofloxacin

Erythromycin

Moderate

Diltiazem

Prednisolone

Triamcinolone

Metformin

Glimepiride

Telmisartan,Amlodipine

Cardivas IN 6.25/5 Tablet Contraindications

If you are suffering from any of the following diseases, you should not take Cardivas IN 6.25/5 Tablet unless your doctor advises you to do so -

Depression
Myasthenia Gravis
Diabetes
Asthma
Bradycardia (Slow Heart Rate)
Peripheral Vascular Disease (PVD)
Liver Disease
Glaucoma
Heart Failure
Bradycardia (Slow Heart Rate)
Arrhythmia
Liver Disease
Low Blood Pressure
Kidney Disease

Frequently asked Questions about Cardivas IN 6.25/5 Tablet

Is this Cardivas IN 6.25/5 Tablet habit forming or addictive?

Cardivas IN 6.25/5 Tablet is not addictive in nature.

Cardivas IN 6.25/5 Tablet Interactions with Food and Alcohol

Interaction between Food and Cardivas IN 6.25/5 Tablet

Cardivas IN 6.25/5 Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Cardivas IN 6.25/5 Tablet

No research has been done on this till date. Therefore, it is not known what the effect of taking Cardivas IN 6.25/5 Tablet with alcohol will be.

See all substitutes for Cardivas IN

This medicine data has been created by -

Vikas Chauhan
B.Pharma, Pharmacy
7 Years of Experience

References

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)

Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Corlanor® (ivabradine)

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 554

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 720-721

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Corlanor® (ivabradine)

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 554

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 720-721

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)

Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Corlanor® (ivabradine)

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 554

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 720-721